TP53 and breast cancer: The remaining 22 BARD1-mutated index patients tested negative for pathogenic variants in further BC/OC predisposition genes (ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, RAD51C, RAD51D, and TP53).